Antibiotic Prophylaxis for Gastrointestinal Surgery among Neonates and Very Young Infants: National Patterns,

Humza Thobani1, Roshni Mathew2, Anam N Ehsan1

  • 1Division of Pediatric Surgery, Department of Surgery, Stanford University, Palo Alto, CA.

The Journal of Pediatrics
|September 28, 2025
PubMed

Insights

Adherence to surgical antibiotic prophylaxis guidelines is low in infants undergoing GI surgery. Broadening antibiotic coverage offers limited benefit for reducing surgical site infections in this population.

Area of Science:

  • Pediatric Surgery
  • Infectious Disease
  • Antimicrobial Stewardship

Background:

  • Surgical antibiotic prophylaxis (SAP) guidelines aim to prevent surgical site infections (SSIs).
  • Adherence to SAP guidelines in neonates and infants undergoing gastrointestinal surgery is not well-established.
  • Optimizing SAP is crucial for balancing infection prevention and antimicrobial resistance.

Purpose of the Study:

  • To evaluate nationwide adherence to surgical antibiotic prophylaxis (SAP) guidelines in neonates and infants undergoing gastrointestinal surgery.
  • To assess the association between SAP guideline adherence and surgical site infection (SSI) rates.
  • To determine the impact of SAP overcoverage and undercoverage on postoperative outcomes.

Main Methods:

  • Utilized the National Surgical Quality Improvement Program-Pediatric database (2021-2023).
  • Included patients <90 days old undergoing select thoracoabdominal procedures.
  • Classified SAP regimens as adherent, undercoverage, or overcoverage; analyzed SSI as the primary outcome.

Main Results:

  • Overall SAP adherence was 87.2% in 11,062 cases.
  • Overcoverage and undercoverage rates varied significantly by procedure type.
  • SAP undercoverage was linked to higher SSI odds only in colorectal procedures (cefazolin monotherapy); overcoverage did not reduce SSI rates.

Conclusions:

  • Nationwide adherence to empiric SAP guidelines is suboptimal in neonates and young infants.
  • Broadening SAP coverage offers limited benefit for reducing SSIs in this patient group.
  • Neonatal-specific data should guide SAP recommendations to optimize outcomes and antimicrobial stewardship.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
451
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
568